# Aethir Related Articles

Axe Compute [NASDAQ: AGPU] Completes Corporate Restructuring (formerly POAI), Enterprise-Grade Decentralized GPU Computing Power Aethir Officially Enters Mainstream Market

Predictive Oncology has officially rebranded as Axe Compute and will trade on NASDAQ under the ticker AGPU. This rebranding signifies the company's shift to operating as an enterprise-level provider, commercializing Aethir's decentralized GPU network to deliver guaranteed computational power for global AI enterprises. Axe Compute's infrastructure is supported by the Aethir Strategic Compute Reserve (SCR), which offers predictable GPU reservations, dedicated computing clusters, and enterprise-grade SLAs to address computational bottlenecks in AI training, inference, and data-intensive workloads. This move marks the first time decentralized GPU infrastructure has entered mainstream capital markets via a U.S. publicly listed company. Axe Compute will serve as the enterprise-facing delivery and contracting entity, while Aethir continues to operate as the underlying decentralized GPU-as-a-Service infrastructure. This structure bridges Web3 decentralized networks with Web2 enterprise demand, allowing businesses to use distributed GPU resources within familiar compliance and procurement frameworks. Aethir's network currently spans 93 countries, over 200 regions, and deploys more than 435,000 GPU containers, supporting high-end hardware like NVIDIA H100, H200, B200, and B300. Axe Compute's model aims to provide guaranteed GPU reservations, dedicated clusters, bare-metal performance, multi-region deployment, and enterprise SLAs—addressing common industry challenges such as long procurement cycles, centralized cloud queues, and price volatility. This represents a significant step in scaling decentralized AI infrastructure for commercial use.

深潮12/12 13:14